Novo Nordisk A/S (BVMF:N1VO34)
41.22
+3.04 (7.96%)
At close: Jan 16, 2026
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.44 trillion as of January 16, 2026. Its market cap has decreased by -41.16% in one year.
Market Cap
1.44T
Enterprise Value
1.50T
Revenue
264.23B
Ranking
n/a
PE Ratio
16.60
Stock Price
41.22
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 7.50B to 1.44T, an increase of 19,132.51%. That is a compound annual growth rate of 19.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.44T | 14.88% |
| Dec 30, 2025 | 1.26T | -47.80% |
| Dec 30, 2024 | 2.40T | 7.38% |
| Dec 29, 2023 | 2.24T | 39.16% |
| Dec 30, 2022 | 1.61T | 13.12% |
| Dec 30, 2021 | 1.42T | 68.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 88.98B |
| Raia Drogasil | 43.24B |
| Hypera | 14.95B |
| Fleury | 8.57B |
| Odontoprev | 5.83B |
| Diagnósticos da América | 4.76B |
| Empreendimentos Pague Menos | 4.26B |
| Blau Farmacêutica | 2.71B |